| Detected | Trial | Change |
|---|---|---|
| 2026-08-11 | NCT06970743 A Study of BGB-16673 Compared to Investigator's Choice in Participants With… |
Trial sites reduced: 62 -> 56 locations |
| 2026-08-11 | NCT07619287 An Investigational Study of BG-75202 Alone and in Combination With Other Agents in… |
Trial sites expanded: 7 -> 10 locations |
| 2026-08-11 | NCT07412691 A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients With… |
Trial sites expanded: 7 -> 11 locations |
| 2026-08-11 | NCT06943872 A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or… |
Trial sites expanded: 192 -> 195 locations |
| 2026-08-11 | NCT07712640 A Study to Investigate the Relative Bioavailability of 2 Tablet Formulations and the… |
Recruitment opened |
| 2026-08-08 | NCT06598800 Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants… |
Trial sites expanded: 26 -> 30 locations |
| 2026-08-08 | NCT06846671 A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic… |
Trial sites expanded: 124 -> 127 locations |
| 2026-08-07 | NCT05006716 A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell… |
Trial sites reduced: 127 -> 114 locations |
| 2026-08-07 | NCT06973187 A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in… |
Trial sites expanded: 197 -> 204 locations |
| 2026-08-07 | NCT07277231 A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With… |
Trial sites expanded: 91 -> 96 locations |
| 2026-08-07 | NCT07492641 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… |
Trial sites expanded: 74 -> 90 locations |
| 2026-08-05 | NCT07619287 An Investigational Study of BG-75202 Alone and in Combination With Other Agents in… |
Trial sites expanded: 4 -> 7 locations |
| 2026-08-04 | NCT06596473 A Study of BG-C477 in Participants With Advanced Solid Tumors |
Trial sites expanded: 54 -> 58 locations |
| 2026-07-30 | NCT06943872 A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or… |
Trial sites expanded: 187 -> 192 locations |
| 2026-07-25 | NCT07492641 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… |
Trial sites expanded: 62 -> 74 locations |
| 2026-07-24 | NCT06973187 A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in… |
Trial sites expanded: 186 -> 197 locations |
| 2026-07-24 | NCT07277231 A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With… |
Trial sites expanded: 88 -> 91 locations |
| 2026-07-24 | NCT05100862 A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants… |
Trial sites expanded: 257 -> 270 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-04 | NCT07746141 A First-in-Human Study Investigating BG-85738 Alone or in Combination With Other… | Phase 1 | Not Yet Recruiting |
| 2026-07-29 | NCT07733180 A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06742996 | A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared… | Mantle Cell Lymphoma | Recruiting |
| NCT06973187 | A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT07277231 | A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT07492641 | BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… | HR+/HER2- Breast Cancer | Recruiting |
| NCT06846671 | A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic… | CLL | Recruiting |
| NCT07043400 | A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus… | Metastatic Gastric Adenocarcinoma | Recruiting |
| NCT06943872 | A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT04002297 | A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With… | Mantle Cell Lymphoma; Non-Hodgkin Lymphoma | Active, Not Recruiting |
| NCT05100862 | A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants… | Relapsed/Refractory Follicular Lymphoma | Active, Not Recruiting |
| NCT06073821 | Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax… | CLL | Active, Not Recruiting |
| NCT06970743 | A Study of BGB-16673 Compared to Investigator's Choice in Participants With… | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT05707377 | A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary… | Primary Membranous Nephropathy | Active, Not Recruiting |
| Phase 2 | |||
| NCT07554521 | A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally… | Advanced Unresectable Gastric Adenocarcinoma | Recruiting |
| NCT05952037 | A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy… | Waldenstrom Macroglobulinemia | Active, Not Recruiting |
| NCT06637501 | A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone… | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT07733180 | A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese… | Advanced Esophageal Squamous Cell Carcinoma | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT04771130 | A Study of BGB-11417 in Participants With Myeloid Malignancies | Acute Myeloid Leukemia | Recruiting |
| NCT06634589 | A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other… | B-cell Malignancy | Recruiting |
| NCT05006716 | A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell… | B-cell Malignancy | Recruiting |
| NCT04973605 | A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations… | Relapsed/Refractory Multiple Myeloma | Recruiting |
| NCT06697184 | A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating… | Chronic Lymphocytic Leukemia | Recruiting |
| Phase 1 | |||
| NCT07181681 | A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents… | Solid Tumors | Recruiting |
| NCT05981703 | A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants… | Advanced Solid Tumor | Recruiting |
| NCT06756932 | BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive… | Hormone-receptor-positive Breast Cancer | Recruiting |
| NCT06233942 | Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other… | Advanced Solid Tumor | Recruiting |